Adam Crystal, M.D., Ph.D.

Adam Crystal, M.D., Ph.D.

President of Research and DevelopmentatTango Therapeutics· In proxies 2023–2025

Pay in FY2025-54% from the year before · Tango Therapeutics stock +186.7% the same year

Adam Crystal, M.D., Ph.D. was paid $1.7M in FY2025 (Dec), down 54%. Tango Therapeutics stock rose 186.7% that year.

Pay$100 in the stock at the end of FY22 → $122
Pay is from the Summary Compensation Table of each Tango Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Tango TherapeuticsPublic company · 3 yr
    • President of Research and Development2023 – Present · 3 yrStock in role +205%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?